|
SYNCRIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99840144432528E-15 |
| Normal-vs-Stage2 |
1.60299995499713E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
3.99680288865056E-15 |
| Stage1-vs-Stage2 |
3.826000E-01 |
| Stage1-vs-Stage3 |
1.958460E-02 |
| Stage1-vs-Stage4 |
3.803600E-03 |
| Stage2-vs-Stage3 |
4.256000E-01 |
| Stage2-vs-Stage4 |
1.888560E-01 |
| Stage3-vs-Stage4 |
4.937600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.90960000000717E-05 |
| Normal-vs-Asian |
3.86340004432384E-09 |
| Caucasian-vs-AfricanAmerican |
1.249420E-01 |
| Caucasian-vs-Asian |
3.090600E-01 |
| AfricanAmerican-vs-Asian |
4.990400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.717430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.91946458727443E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.575500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.293900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.329770E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.750000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.806400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.107400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.321400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.936800E-03 |
| Classical-VS-Follicular |
3.445800E-01 |
| Classical-VS-Other |
3.749000E-01 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
8.408400E-02 |
| Tall-VS-Other |
6.709800E-01 |
| Tall-VS-Normal |
1.16351372980716E-13 |
| Follicular-VS-Other |
6.685400E-01 |
| Follicular-VS-Normal |
1.75409686775652E-11 |
| Other-VS-Normal |
3.007800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.8273164899324E-12 |
| N0-vs-N1 |
8.022000E-01 |
|
|
